{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:16:01Z","timestamp":1777439761272,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ejphar.2016.11.034","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T07:31:32Z","timestamp":1479886292000},"page":"193-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Pharmacological effects of a recombinant hPTH(1\u221234) derived peptide on ovariectomized rats"],"prefix":"10.1016","volume":"794","author":[{"given":"Wang","family":"Chunxiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gu","family":"Chengying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Xiaoming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Junting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu","family":"Wenhui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Jingjing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2016.11.034_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0083-6729(08)60407-0","article-title":"Cytokine regulation of bone cell differentiation","volume":"52","author":"Alsina","year":"1996","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.ejphar.2016.11.034_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.regpep.2006.12.020","article-title":"Study on preparation and activity of a novel recombinant human parathyroid hormone (1\u201334) analog with N-terminal Pro-Pro extension","volume":"141","author":"Chunxiao","year":"2007","journal-title":"Regul. Pept."},{"issue":"1","key":"10.1016\/j.ejphar.2016.11.034_bib3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pep.2011.04.017","article-title":"Biosynthesis of a novel recombinant peptide derived from hPTH(1-34)","volume":"79","author":"Chunxiao","year":"2011","journal-title":"Protein Expres Purif."},{"issue":"5","key":"10.1016\/j.ejphar.2016.11.034_bib4","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.ejps.2012.09.013","article-title":"Impacts of the N-terminal fragment analogue of human parathyroid hormone on structure, composition and biomechanics of bone","volume":"47","author":"Chunxiao","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ejphar.2016.11.034_bib5","first-page":"E27","article-title":"Skeletal effects of parathyroid hormone (1\u201334) in ovariectomized rats with or without concurrent administration of salmon calcitonin","volume":"3","author":"Dani","year":"2001","journal-title":"Am. Assoc. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2016.11.034_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/jcp.45.1.68","article-title":"Evaluation of two new methods for routine measurement of alkaline phosphatase isoenzymes","volume":"45","author":"Day","year":"1992","journal-title":"J. Clin. Pathol."},{"issue":"7","key":"10.1016\/j.ejphar.2016.11.034_bib7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3949\/ccjm.70.7.585","article-title":"Recombinant human PTH 1-34 (Forteo): an anabolic drug for osteoporosis","volume":"70","author":"Deal","year":"2003","journal-title":"Cleve Clin. J. Med."},{"issue":"4","key":"10.1016\/j.ejphar.2016.11.034_bib8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00223-006-0108-1","article-title":"Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength","volume":"79","author":"Fox","year":"2006","journal-title":"Calc. Tissue Int."},{"key":"10.1016\/j.ejphar.2016.11.034_bib9","doi-asserted-by":"crossref","first-page":"F975","DOI":"10.1152\/ajprenal.00336.2005","article-title":"PTH(1-84)\/PTH(7-84): a balance of power","volume":"290","author":"Friedman","year":"2006","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"5","key":"10.1016\/j.ejphar.2016.11.034_bib10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1076\/apab.105.5.435.3292","article-title":"Influence of ovariectomy and estradiol treatment on calcium homeostasis during aging in rats","volume":"105","author":"Gaumet","year":"1997","journal-title":"Arch. Physiol. Biochem"},{"key":"10.1016\/j.ejphar.2016.11.034_bib11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.22203\/eCM.v020a18","article-title":"Addition of hydroxyapatite improves stiffness, interconnectivity and osteogenic potential of a highly porous collagen-based scaffold for bone tissue regeneration","volume":"20","author":"Gleeson","year":"2010","journal-title":"Eur. Cells Mater."},{"issue":"32","key":"10.1016\/j.ejphar.2016.11.034_bib12","first-page":"5959","article-title":"Effects of eucommia water\/alcohol extract on proliferation and osteogenic differentiation ofrabbit adipose derived mesenchymal stem cells","volume":"16","author":"Guo","year":"2012","journal-title":"CJTER"},{"issue":"6","key":"10.1016\/j.ejphar.2016.11.034_bib13","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1093\/jn\/130.6.1543","article-title":"Hyperparathyroidism is augmented by ovariectomy in nagase analbuminemic rats","volume":"130","author":"Inaba","year":"2000","journal-title":"J. Nutr."},{"issue":"12","key":"10.1016\/j.ejphar.2016.11.034_bib14","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1172\/JCI119491","article-title":"Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells","volume":"99","author":"Ishizuya","year":"1997","journal-title":"J. Clin. Invest"},{"issue":"10","key":"10.1016\/j.ejphar.2016.11.034_bib15","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/jbmr.5650111003","article-title":"Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages","volume":"11","author":"Isogai","year":"1996","journal-title":"J. Bone Min. Res"},{"issue":"7","key":"10.1016\/j.ejphar.2016.11.034_bib16","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1210\/endo.143.7.8884","article-title":"Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats","volume":"143","author":"Iwaniec","year":"2002","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.ejphar.2016.11.034_bib17","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/jbmr.5650101007","article-title":"Intermittent treatment with human parathyroid hormone (hPTH[1\u201334]) increased trabecular bone volume but not connectivity in osteopenic rats","volume":"10","author":"Lane","year":"1995","journal-title":"J. Bone Min. Res."},{"issue":"12","key":"10.1016\/j.ejphar.2016.11.034_bib18","doi-asserted-by":"crossref","first-page":"e1001251","DOI":"10.1371\/journal.pgen.1001251","article-title":"Thymus-associated parathyroid hormone has two cellular origins with distinct endocrine and immunological functions","volume":"6","author":"Liu","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ejphar.2016.11.034_bib19","doi-asserted-by":"crossref","first-page":"10778","DOI":"10.1038\/srep10778","article-title":"Decoupling the role of stiffness from other hydroxyapatite signalling cues in periosteal derived stem cell differentiation","volume":"5","author":"Mattei","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejphar.2016.11.034_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/ciia.2007.2.1.55","article-title":"The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis","volume":"2","author":"Migliaccio","year":"2007","journal-title":"Clin. Inter. Aging"},{"issue":"6","key":"10.1016\/j.ejphar.2016.11.034_bib21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1043-2760(97)00060-X","article-title":"Anabolic Effects of Parathyroid Hormone on Bone","volume":"8","author":"Morley","year":"1997","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ejphar.2016.11.034_bib22","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1006\/bbrc.1994.1653","article-title":"Production of Human PTH(1-34) via a Recombinant DNA Technique","volume":"200","author":"Nakagawa","year":"1994","journal-title":"Biochem Biophys. Res Commun."},{"issue":"6","key":"10.1016\/j.ejphar.2016.11.034_bib23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units","volume":"2","author":"Parfitt","year":"1987","journal-title":"J. Bone Min. Res"},{"key":"10.1016\/j.ejphar.2016.11.034_bib24","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1021\/la204052a","article-title":"Thickness of hydroxyapatite nanocrystal controls mechanical properties of the collagen\u2013hydroxyapatite interface","volume":"28","author":"Qin","year":"2012","journal-title":"Langmuir"},{"issue":"64233A","key":"10.1016\/j.ejphar.2016.11.034_bib25","first-page":"1","article-title":"The influence of Ca\/P ratio on the properties of hydroxyapatite bioceramics","volume":"6423","author":"Ramesh","year":"2007","journal-title":"Proc SPIE"},{"key":"10.1016\/j.ejphar.2016.11.034_bib26","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1172\/JCI116483","article-title":"Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol","volume":"91","author":"Shen","year":"1993","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.ejphar.2016.11.034_bib27","first-page":"21836","article-title":"Minimization of parathyroid hormone","volume":"275","author":"Shimizu","year":"2000","journal-title":"novel amino-terminal parathyroid hormone fragments with enhanced potency in activating the type-1 parathyroid hormone receptor. J Biol Chem."},{"issue":"5","key":"10.1016\/j.ejphar.2016.11.034_bib28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S8756-3282(97)00020-3","article-title":"A comparison of the effects of two anabolic agents(fluoride and PTH) on ash density and bone strength assessed in an osteopenic rat model","volume":"20","author":"Sogaard","year":"1997","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.ejphar.2016.11.034_bib29","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pep.2003.11.012","article-title":"Production and enhanced biological activity of a novel GHRH analog, hGHRH with an N-terminal Pro-Pro extension","volume":"34","author":"Tang","year":"2004","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ejphar.2016.11.034_bib30","series-title":"Experimental and Surgical Techniques in the Rat","first-page":"276","article-title":"Specific Surgical Operations","author":"Waynforth","year":"1992"},{"key":"10.1016\/j.ejphar.2016.11.034_bib31","series-title":"Experimental Methodology of pharmacology","author":"Wei","year":"2010"},{"issue":"11","key":"10.1016\/j.ejphar.2016.11.034_bib32","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0165-6147(00)89079-3","article-title":"Small bone-building fragments of parathyroid hormone: new therapeutic agents for osteoporosis","volume":"16","author":"Whitfield","year":"1995","journal-title":"Trends Pharm."},{"issue":"1","key":"10.1016\/j.ejphar.2016.11.034_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s002239900181","article-title":"Comparison of the ability of recombinant human parathyroid hormone, rhPTH-(1-84), and hPTH-(1-31)NH2 to stimulate femoral trabecular bone growth in ovariectomized rats","volume":"60","author":"Whitfield","year":"1997","journal-title":"Calcif. Tissue Int."},{"issue":"1\u20133","key":"10.1016\/j.ejphar.2016.11.034_bib34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.regpep.2009.06.001","article-title":"Study on preparation and unique properties of a novel insulin analogue with N-terminal Arg-4, Pro-3, Lys-2, Pro-1extension at insulin B-chain","volume":"157","author":"Yong","year":"2009","journal-title":"Regul. Pept."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916307385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916307385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T21:55:52Z","timestamp":1568584552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299916307385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":34,"alternative-id":["S0014299916307385"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.11.034","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological effects of a recombinant hPTH(1\u221234) derived peptide on ovariectomized rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.11.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}